Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 3/20 | 0.46 |
| ▸ | GRM5 | P41594 | 7/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTR1D | P28221 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9306983 | 1.00 | KCNH2 (0.46) | KCNH2GRM5EGFRKCNA3CA12 | |
| SCHEMBL28450613 | 0.83 | KCNH2 (0.50) | KCNH2GRM5EGFRKCNA3CA12 | |
| SCHEMBL9307406 | 0.78 | KCNH2 (0.42) | KCNH2EGFRKCNA3CA12CA1 | |
| SCHEMBL9307399 | 0.78 | KCNH2 (0.42) | KCNH2EGFRKCNA3CA12CA1 | |
| SCHEMBL9307301 | 0.76 | KCNH2 (0.44) | KCNH2EGFRKCNA3CA12CA1 | |
| SCHEMBL9307305 | 0.76 | KCNH2 (0.44) | KCNH2EGFRKCNA3CA12CA1 | |
| SCHEMBL9808291 | 0.72 | KCNH2 (0.57) | KCNH2EGFRKCNA3CA12CA1 | |
| SCHEMBL12314514 | 0.72 | GRM5 (0.49) | KCNH2GRM5 | |
| SCHEMBL5570294 | 0.70 | CHRNB2 (0.47) | LMNA | |
| SCHEMBL9338770 | 0.69 | KCNH2 (0.55) | KCNH2KCNA3CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5318989-A | Antitumor and -carcinogenic agents; antibiotics; aglycones of esperamycins and calichemicins and having the same mechanism of bioactivity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-06-07 | — | — | US | disclosed |
| EP-0538898-A2 | Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof | Bristol-Myers Squibb Company (US) | 1993-04-28 | — | — | EP | disclosed |
| US-5198560-A | Antitumor agents based on esperamicin antibiotics | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-03-30 | — | — | US | disclosed |